Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.99 USD | +1.53% | +18.65% | -28.98% |
05-02 | CUREVAC : A missed opportunity | |
04-26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.98% | 670M | |
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+48.94% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac N : On Track to Provide Data for Conditional Approval of COVID-19 Vaccine Candidate in Europe